glp 1 glucagon dual receptor agonist Targeting GLP-1, GIP & GCG in Obesity and Type 2 Diabetes Research PDB-101: Molecule of the Month:
Description
The DPP-4 inhibitors offer the advantage of no weight gain
But they may get worse if you eat high-fat foods
It is notable that high spikes of blood insulin, (Hyperinsulinemia), initiates inflammation, which over times causes atherosclerosis and its sequela cardiovascular heart disease (CHD)
GLP-1 receptor agonists and risk of cancer in type 2 diabetes: an updated meta-analysis of randomized controlled trials
As more people use these drugs, they're raising big questions about health, who we are, and the future of food-based businesses
van Buuren, S
